ImmunityBio, Inc.·4

Feb 12, 8:17 PM ET

SOON-SHIONG PATRICK 4

4 · ImmunityBio, Inc. · Filed Feb 12, 2025

Insider Transaction Report

Form 4
Period: 2025-02-10
SOON-SHIONG PATRICK
DirectorSee remarks10% Owner
Transactions
  • Award

    Restricted Stock Units

    2025-02-10+822,368822,368 total
    Common Stock (822,368 underlying)
  • Award

    Stock Option (right to buy)

    2025-02-10+2,812,5002,812,500 total
    Exercise: $3.39Exp: 2035-02-10Common Stock (2,812,500 underlying)
Footnotes (3)
  • [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of ImmunityBio, Inc. (the "Issuer") common stock.
  • [F2]Subject to the reporting person's continuing to be a Service Provider (as defined in the Issuer's Amended and Restated 2015 Equity Incentive Plan) through each applicable vesting date, 33.33% of the shares subject to the RSU award shall vest in equal annual installments on each of the first and second anniversaries of the vesting commencement date and 33.34% of the shares subject to the RSU award shall vest on the third anniversary of the vesting commencement date, such that all shares shall be fully vested on the third anniversary of the vesting commencement date. The vesting commencement date for this RSU award is February 10, 2025.
  • [F3]Subject to the reporting person's continuing to be a Service Provider (as defined in the Issuer's Amended and Restated 2015 Equity Incentive Plan) through each applicable vesting date, 33.33% of the shares subject to the option shall vest in equal annual installments on each of the first and second anniversaries of the vesting commencement date and 33.34% of the shares subject to the option shall vest on the third anniversary of the vesting commencement date, such that all shares shall be fully vested on the third anniversary of the vesting commencement date. The vesting commencement date for this option is February 10, 2025.

Documents

1 file
  • 4
    wk-form4_1739409423.xmlPrimary

    FORM 4